Galvanize Therapeutics, Inc.
New Form D on file · 2026-11-18 · the record
Before you sell to, join or invest in Galvanize Therapeutics, Inc.
MentionFox check on Galvanize Therapeutics, Inc.: only 1 source on file so far (checked 19 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/galvanize-therapeutics-inc-form-d-000004
Check Galvanize Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Galvanize Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-18.
Galvanize Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 18, 2026. Galvanize Therapeutics, Inc. was formerly named Gala Therapeutics, Inc. The filing reports $136.19M sold. Its industry group is Biotechnology. It names Doug Godshall (Executive Officer, Director), Seth Harrison (Director), Antoine Papiernik (Director) (SEC Form D, November 18, 2026).
In its own words: “Galvanize Therapeutics designs pulsed electric field energy devices for the surgical ablation of soft tissue, engineered to work with the body's biology.” (galvanizetx.com, checked November 19, 2026)
Sell to companies like Galvanize Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Galvanize Therapeutics, Inc. raised on Nov 18. 137 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Linework USA INC. | $1.2B | AI and software |
| Linework USA INC. | $326M | AI and software |
| Pathos AI, Inc. | $238M | Biotech |
| Galvanize Therapeutics, Inc. | $136M | Biotech |
| Tractian Inc. | $106M | AI and software |
Selling to Galvanize Therapeutics, Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.
Is this your company?
New Form D on file · 2026-11-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Galvanize Therapeutics, Inc.
Free to see. No signup.
Get an email when Galvanize Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Galvanize Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Galvanize Therapeutics, Inc. →Get the full cited report on Galvanize Therapeutics, Inc.
What the filing shows about Galvanize Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Galvanize Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look Galvanize Therapeutics, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Galvanize Therapeutics, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives Galvanize Therapeutics, Inc.'s address as 3200 Bridge Parkway, Redwood City, CA 94065.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Galvanize Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Galvanize Therapeutics, Inc. See pricing
Galvanize Therapeutics, Inc. is a registered filer with the SEC (CIK 1659073) and has filed since 2025-09-11. 2 filings are on record, the latest on 2026-11-18.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Galvanize Therapeutics, Inc.'s Form D of 2026-11-18 names Doug Godshall, Seth Harrison, Antoine Papiernik and 6 more as its officers, directors or promoters.
Its new offerings report $232.32M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 758 filings in Biotechnology, totalled by week. The dot is this raise, $136.19M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Doug Godshall is named as Executive Officer and Director on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
Seth Harrison is named as Director on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
Antoine Papiernik is named as Director on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
Zack Scott is named as Director on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
David Lewis is named as Director on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
Steve Anheier is named as Executive Officer on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
Isaac Zacharias is named as Director on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
Laura Francis is named as Director on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
Garheng Kong is named as Director on the Form D that Galvanize Therapeutics, Inc. filed with the SEC on 18 November 2026, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role and 7 as directors only.
Named as of the 2026-11-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Galvanize Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Galvanize Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Galvanize Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
9 people named on this filing See who they are
Start a free 5-day trial →You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Galvanize Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Galvanize Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: San Francisco Bay Area raises, week of 2026-11-16 · Biotech raises, week of 2026-11-16 · Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/galvanize-therapeutics-inc-form-d-000004